Skip To Main Content
JMS Bartlett on Muck Rack

JMS Bartlett

As seen in: Journal of Clinical Pathology
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with JMS

Contact JMS, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Tumour infiltrating lymphocytes and stromal CD68 in early stage HER2 positive breast cancer

|
By Jacques Raphael, IY Gong, S Nofech-Mozes, JMS Bartlett, H Nafisi
| Journal of Clinical Pathology Verified
High levels of tumour infiltrating lymphocytes (TILs) at diagnosis were shown to be associated with decreased distant recurrence rates in triple negative breast cancer (BC) and increased trastuzumab (T) benefit in HER2+ disease.1 However, conflicting data showed that HER2+ cases with high TILs might not benefit from the addition of T to chemotherapy.2 Moreover, emerging literature suggests association between high tumour-associated macrophages (TAMs) and poor prognosis in patients with BC.3...
Open in Who Shared Issue with article?
See all 1 articles